Innovations in care: neonatal home antibiotic infusion therapy

J M Anastasi1

  • 1University of Maryland Medical Systems, NICU Follow-Up Program, Baltimore 21201-1595, USA.

Neonatal Network : NN
|July 21, 1998
PubMed

Insights

Home antibiotic infusion therapy offers a novel approach for treating infections in stable newborns. Specialized home care programs are essential for this unique patient population, ensuring safe and effective treatment outside the hospital.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Home Healthcare

Background:

  • Home care is increasingly utilized for acute and chronic conditions, shifting from traditional hospital stays.
  • Antibiotic infusion therapy at home presents an innovative treatment option for specific patient groups.
  • Neonates require tailored programs for home intravenous (IV) therapy due to their unique physiological needs.

Observation:

  • Stable term infants with suspected or confirmed infections can receive antibiotic infusion therapy at home.
  • This approach necessitates the development of specialized programs designed for neonates.
  • The article details a specific program established for home antibiotic infusion in neonates.

Findings:

  • The described program facilitates the safe and effective delivery of antibiotic infusion therapy to neonates in a home setting.
  • It addresses the unique challenges and requirements of providing IV therapy to this vulnerable population.
  • The program's structure ensures continuity of care and appropriate monitoring for infants receiving treatment at home.

Implications:

  • Successful home care programs for neonatal antibiotic infusion can reduce hospitalizations and associated costs.
  • This model can improve family-centered care by allowing infants to recover in a familiar environment.
  • The development and implementation of such specialized programs are crucial for advancing pediatric home healthcare.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...